Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
Date:9/25/2007

Conference Call to Be Held Tomorrow, Wednesday, September 26th at 8:30am

NEW YORK, Sept. 25 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced today that it will conduct a conference call to discuss a strategic alliance surrounding one of its Phase II portfolio products for a territory outside the US.

The call will take place tomorrow, Wednesday, September 26, 2007, at 8:30am EDT. Michael S. Weiss, Chairman and CEO of Keryx Biopharmaceuticals will host the call.

Interested parties may participate in the call by dialing 1-877-719-9796 (U.S.), 1-719-325-4777 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference call will be available for replay at http://www.keryx.com, for a period of 15 days after the call.

ABOUT KERYX BIOPHARMACEUTICALS, INC.

Keryx Biopharmaceuticals, Inc. is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide), previously referred to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Sulonex is in a pivotal Phase III and Phase IV clinical program under a Special Protocol Assessment with the Food & Drug Administration. Additionally, Keryx is developing Zerenex(TM), an oral, inorganic, iron-based compound that has the capacity to bind phosphate and form non-absorbable complexes. Zerenex is currently in Phase II clinical development for the treatment of hyperphosphatem
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...-TwomoreprestigiousuniversitieshavejoinedBioCareer...iteforlifescienceprofessionals. ,, Northwestern...ining28othermajorlifesciencetrainingInstitutions. ...forpost-graduatesinthelifesciences.Whiletherearehu...eerCenteristheonlyonethatserveslifesciencepost-gra...
(Date:11/24/2009)...ire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN ...ionsbytheU.S.BankruptcyCourtfortheDistrictofDelawa...ntarypetitionfor,reliefunderChapter11oftheUnitedSt...TheordersissuedbytheBankruptcyCourtallowthecompany...roceedings.Inparticular,the,companyreceivedinterim...
(Date:11/24/2009)...pproved the Promega PowerPlex 16 HS System for use...A records for the National DNA Index System. , ...he FBI recently approved the Promega PowerPlex&re...ting in, or generating DNA records for, the Nation...s more than seven million profiles and has assiste...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2
..., Calif., May 28 CV Therapeutics,Inc. (Nasdaq: C...daq,marketplace rule 4350, the Company issued new ...ers due to additional hiring, primarily in connect...ed States., The inducement stock options cover an...classified as non-qualified stock options with an,...
...Genmab Reports Results for the First Three Months ...N),announced today results for the three month per...ab reported the following results:, Genmab,s reve... for the,first quarter of 2008. In the same period...lion (approx. USD 17 million)., An operating loss...
...hio, May 28 The automation of,transaction-based p...alth,plans in the United States. Foresight Corpora...mber and scale of installations of Transaction,Ins...n automation., Transaction automation techniques ... costs significantly by integrating validation, er...
Other Biology Technology:CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 2Genmab Announces 2008 First Quarter Results 2Genmab Announces 2008 First Quarter Results 3Genmab Announces 2008 First Quarter Results 4New Trend Sweeping Nation's Health Plans: Transaction Automation 2
(Date:11/23/2009)...urrent research suggests that a common oral bacter...d report by Nichols et al, "Unique Lipids from a C...2 Ligands Capable of Enhancing Autoimmunity," appe...urnal of Pathology . , Multiple sclerosis (MS), ...n and spinal cord, affects nearly 1 in 700 people ...
(Date:11/23/2009)... - By producing some of the highest resolution ima...entists have a deeper understanding how biomolecul...ay lead to a new treatment for kidney stones using...the Nov. 23 online edition of the journal Proceed...s how peptides interact with mineral surfaces by a...
(Date:11/23/2009)...niversity of New Hampshire microbiologist Louis Ti...vance understanding of the actinorhizal plants, wi...rient-poor and contaminated soils. , The United...isa, a professor of molecular, cellular and biomed...elationship between the bacteria Frankia and Casua...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 1Psoriasis Video Contest Launched to Encourage Psoriasis Patients to Connect and Collaborate 54344 2Scientists Reverse Multiple Sclerosis in Mice 54342 1Scientists Reverse Multiple Sclerosis in Mice 54342 2Human mind 3A Sound and vision wired through same black box 54340 1Human mind 3A Sound and vision wired through same black box 54340 2
...ies are repairing the human body in ways never ima...n increasing population of patients who are newly ...nd chronic fungal infections have become a formida... Aspergillus fumigatus , the focus of a new text f... engineered to offer the latest insights into the ...
...le in Spanish . , , The conditioning Works of S...unt of vegetable species. The researchers of the ...d to grow in the laboratory two native bushy speci...e cover restoration. They will try to use them to ... Sierra Nevada . , The vegetable species of Sierr...
...ke Salmonella typhimurium employ a startling arr...efense mechanisms and produce illness. Through th...ocks of cellular physiologysuch microbes ingenious...isease-causing potential or virulence. , Althou...ce factors is now well advanced, many pieces of th...
Other Biology News:New text focuses on formidable opportunistic fungus 2An essay proves that vegetation could recover in the ski resort of Sierra Nevada 2The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 2The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 3The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 4The medium is the message: Manipulating salmonella in spaceflight curtails infectiousness 5
...throughput protein crystallography involves using ...ut Screening (HTS). The liquid handling requiremen...itional crystallography plates have 24 or 48 wells...her throughput, the number of wells has increased ...
...everse-iT™ One-Step Kit is the ultimate in co...CR. It has been specifically designed to streamlin...ep Kit combines the unique Reverse-iT™ Blend ...olymerase to provide a highly sensitive, reproduci...
...nogen: Synthetic Peptide: M(1) E F L P E P Q H P ...racting protein 3 (Mint3) from mouse cells.,P...procedures. By Western blot, this antibody detect... cell extract.,PA1-072 immunizing peptide cor...
Custom LNA Oligonucleotide synthesis from Exiqon
Biology Products: